OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 44 of 45

45 Obesity and Binge Eating Disorder   ➤ Recommend cognitive behavior therapy with or without behavioral weight loss.   ➤ Lisdexamfetamine dimesylate is the only pharmacotherapy with an FDA indication to treat binge-eating disorder.   ➤ Although not FDA-approved for this use, clinical trials suggest efficacy for other pharmacotherapies, including SSRIs, topiramate with or without phentermine, and naltrexone-bupropion. Obesity and Night Eating Syndrome   ➤ Treatment includes behavioral therapy regarding nutritional timing and content.   ➤ While not an FDA-indicated use, SSRIs (e.g., sertraline) or topiramate may be helpful for night eating syndrome. Obesity and ADHD   ➤ Pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) with stimulant medications that target core symptoms, like impulsivity and inattention, may lead to weight stabilization or reduction in some individuals, potentially through improved self-regulation, reduced impulsivity, and enhanced executive function.   ➤ Patients with ADHD may benefit from integrated care addressing both physical and psychological health, with adjunct therapies like dialectical behavior therapy, motivational interviewing, and mindfulness, potentially improving outcomes. References Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/ NLA/PCNA Guideline on the Management of Dyslipidemia. JACC. Published online March 2026. doi:https://doi. org/10.1016/j.jacc.2025.11.016 Kanbay M, Copur S, Sarafidis P, Ferro CJ, Ortiz A. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/ AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: a commentary from the European Renal Best Practice (ERBP). Nephrolog y Dialysis Transplantation. Published online March 10, 2026. doi:https://doi.org/10.1093/ndt/gfag055 Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease. Hepatolog y. 2023;77(5):10.1097/HEP.0000000000000323. doi:https://doi.org/10.1097/HEP.0000000000000323 Ozdemir M. 2014 European Society of Cardiolog y Guidelines on Hypertrophic Cardiomyopathy. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiolog y. 2014;42(8):693-697. doi:https://doi.org/10.5543/ tkda.2014.34984 Desai M, Ruan W, osani NC, et al. American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: summary and recommendations. Gastrointestinal Endoscopy. Published online December 1, 2024. doi:https://doi.org/10.1016/j.gie.2024.10.008

Articles in this issue

Links on this page

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026